Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics

被引：3
|
作者：
Sarah, Allegra [1 ,2 ]
Dondi, Emma [1 ]
De Francia, Silvia [1 ]
机构：
[1] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Orbassano, TO, Italy
[2] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Clin Pharmacol Serv Franco Ghezzo, Reg Gonzole 10, I-10043 Turin, TO, Italy
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2023年 / 19卷 / 11期
关键词：
Chemotherapy; Cancer; Precision Medicine; Personalized Treatment; IMATINIB;
D O I：
10.1080/17425255.2023.2277758
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：733 / 739
页数：7
相关论文
共 50 条
  • [21] Tyrosine Kinase Inhibitors
    Natoli, C.
    Perrucci, B.
    Perrotti, F.
    Falchi, L.
    Iacobelli, S.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (05) : 462 - 483
  • [22] Study of the role of pharmacogenetics in the pharmacokinetics of galantamine
    De Antonio, Andrea Guzman
    Garcia, Lucia Diaz
    De Soto, Lucia Martinez
    Perez, Alberto M. Borobia
    Sansuan, Antonio J. Carcas
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 37 - 37
  • [23] Exploring the Role of Chemical Reactions in the Selectivity of Tyrosine Kinase Inhibitors
    Asadi, Mojgan
    Xie, Wen Jun
    Warshel, Arieh
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (36) : 16638 - 16646
  • [24] Role of tyrosine kinase inhibitors in the treatment of advanced colorectal cancer
    Gravalos, Cristina
    Cassinello, Javier
    Fernandez-Ranada, Isabel
    Holgado, Esther
    CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 691 - 699
  • [25] Role of Spleen Tyrosine Kinase Inhibitors in the Management of Rheumatoid Arthritis
    Scott, David L.
    DRUGS, 2011, 71 (09) : 1121 - 1132
  • [26] The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
    Pophali, Priyanka A.
    Patnaik, Mrinal M.
    CANCER JOURNAL, 2016, 22 (01): : 40 - 50
  • [27] Role of Spleen Tyrosine Kinase Inhibitors in the Management of Rheumatoid Arthritis
    David L. Scott
    Drugs, 2011, 71 : 1121 - 1132
  • [28] THE ROLE OF AXL IN ACQUIRED RESISTANCE TO EGFR TYROSINE KINASE INHIBITORS
    Lee, Jae Cheol
    Jang, Se Jin
    Choi, Chang-Min
    Kim, Kyu-Pyo
    Lee, Dae-Ho
    Kim, Sang-We
    Lee, Jung-Shin
    Kim, Woo Sung
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S678 - S678
  • [29] Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors
    Filippi, I.
    Naldini, A.
    Carraro, F.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (19) : 2885 - 2892
  • [30] THE ROLE OF ABC TRANSPORTERS IN RESISTANCE TO ANTICANCER TYROSINE KINASE INHIBITORS
    Sarkadi, Balazs
    Ozvegy-Laczka, Csilla
    Hegedus, Csilla
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3472 - 3472
12345